TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 1 | -1 | -8 | -21 | -43 | 0 | -15 |
| P | %wins | 50 | 0 | 50 | 0 | 0 | 20 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/5/11 11:08 | 8/4/11 | HGSI | Human Genome Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Goddard Colin | MD | D | P | 49 | 16.17 | 33 | 3 | 57 | 8 | D | 4 | -43 | -39 | -44 | -39 | -33 | -27 | -21 | 2 | -1 | -23 | -36 | -34 | ||
3/23/11 15:08 | 3/22/11 | HGSI | Human Genome Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Goddard Colin | MD | D | P | 75 | 27.41 | 33 | 3 | New | 3 | D | 999 | -16 | -9 | 13 | 8 | 7 | -3 | 0 | -1 | -1 | 7 | -6 | -52 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |